| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Nkarta, Inc. | Chief Medical Officer, Head of Research & Development | Common Stock | 70,000 | $134,169 | $1.92 | 06 Jan 2026 | Direct |
| Nkarta, Inc. | Chief Medical Officer, Head of Research & Development | Stock Option (right to buy) | 139,000 | 06 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NKTX | Nkarta, Inc. | 06 Jan 2026 | 2 | $0 | 4 | Chief Medical Officer, Head of Research & Development | 08 Jan 2026, 17:50 |
| NKTX | Nkarta, Inc. | 23 Jun 2025 | 1 | $0 | 4 | Chief Medical Officer, Head of Research & Development | 25 Jun 2025, 16:00 |
| NKTX | Nkarta, Inc. | 23 Jun 2025 | 0 | $0 | 3 | Chief Medical Officer, Head of Research & Development, Exhibit List: Exhibit 24 - Power of Attorney | 25 Jun 2025, 16:00 |